KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other financing activities (2018 - 2019)

Historic Other financing activities for Moderna (MRNA) over the last 2 years, with Q4 2019 value amounting to -$3.7 million.

  • Moderna's Other financing activities fell 13719.66% to -$3.7 million in Q4 2019 from the same period last year, while for Sep 2019 it was $13.6 million, marking a year-over-year change of. This contributed to the annual value of $11.6 million for FY2018, which is 32712.92% up from last year.
  • Per Moderna's latest filing, its Other financing activities stood at -$3.7 million for Q4 2019, which was down 13719.66% from $3.7 million recorded in Q2 2019.
  • Moderna's Other financing activities' 5-year high stood at $9.9 million during Q4 2018, with a 5-year trough of -$3.7 million in Q4 2019.